KANEKA UBIQUINOL™ WINS COVETED MARKETING AWARD 2025 AT NATURAL HEALTH PRODUCTS NEW ZEALAND SUMMIT

Underscoring Kaneka Ubiquinol™’s ongoing commitment to excellence in the natural health industry

Christchurch, New Zealand, 18 June 2025

Kaneka Corporation Supplement Division APAC, the world-renowned manufacturer and global supplier of Ubiquinol is thrilled to announce that Kaneka Ubiquinol™ has been awarded the prestigious Forbes Packaging Marketing Award 2025 at the Natural Health Products New Zealand (NHPNZ) Summit further elevating the brand’s position and stature in the natural health industry across the APAC region.

The company’s win reflects Kaneka Ubiquinol’s™ outstanding efforts and celebrates the strategic impact, scientific credibility and executional excellence of its multi-channel marketing programs which have worked to reach, engage and build trust with brand holders, healthcare professionals, pharmacists, media and consumers alike.

As a result, this has helped to shift the narrative about the way we talk about energy, cardiovascular health and healthy ageing – firmly positioning mitochondrial health and Ubiquinol as the new frontier for optimal health and evidence-based wellbeing.

As the sole global supplier of Ubiquinol worldwide, Kaneka Corporation sets the global standard for nutraceutical science, manufacturing quality and brand integrity. A key point of difference that makes Kaneka Ubiquinol™ stand out in market is its unique production process, being the only Ubiquinol produced via precision yeast fermentation, using patented Japanese processes. This helps to create a structurally identical form of Ubiquinol to that naturally produced in the body – delivering a premium, clinically proven ingredient that supports mitochondrial health and healthy ageing.

Tsuyoshi Takakuwu, Head of Marketing & Sales (APAC) Supplemental Nutrition Business Division, Kaneka Corporation, Japan, said he was deeply honoured to receive the prestigious award – a reflection of the brand’s deep focus on science, education and partnerships to position mitochondrial health as the new frontier of evidence-based wellbeing.

“This recognition reflects the collective efforts of our marketing, science, R&D teams, healthcare practitioner partners, brandholders and, importantly consumers, united by a shared commitment to science, quality, education and a long-term vision to position Ubiquinol as as the definitive standard in mitochondrial health,” he added.

Kazuki Takita, Oceanian & Asian Marketing & Sales Team, Supplement Business Group, Supplement Strategic Unit, added that the award is a powerful testament of the success of the brand’s multi-market, multi-channel strategy, which supports Kaneka Ubiquinol™’s presence and credibility across the APAC region.

“This award illustrates our strategic vision: to position Kaneka Ubiquinol™ as a trusted ingredient for healthcare professionals, a premium asset for brandholders, and a clinically supported natural health product for consumers seeking high-quality, evidence-based supplementation to support their overall health and wellbeing,” he continued.

“We thank NHPNZ and the judging panel for this honour and extend our congratulations to all the other finalists and winners.”

Kaneka Ubiquinol™ is supported by over 100 scientific studies, 80+ global patents, and 45+ years of cutting-edge research, with applications spanning mitochondrial health, cardiovascular health, cognitive function, women’s health, fertility, energy production healthy ageing.

Achieving an industry award at the NHPNZ Summit 2025 is a mark of distinction, celebrating brands and innovators who are setting the pace and raising the bar for excellence across the natural health sector. Kaneka Ubiquinol™’s win signifies the brand’s leadership in marketing and ability to set new standards – demonstrating unparalleled creativity, engagement and measurable business impact.